Our Studies

A Study investigating the safety and efficacy of once weekly NNC0519-0130 in participants with type 2 diabetes mellitus.

ZEUS Study - Effects of ziltivekimab versus placebo on cardiovascular outcomes in participants with established atherosclerotic cardiovascular disease, chronic kidney disease, and systemic inflammation.

SOUL Study - A Randomized, double-blind, parallel-group, placebo-controlled trial comparing oral semaglutide vs. placeboOD added to standard of care in patients with T2D at high risk of CV events.

PIONEER Study - Efficacy and safety of once-daily oral semaglutide 25mg and 50 mg compared with 14mg in subjects with type 2 diabetes.

COMBINE Study - A 52 week study comparing the efficacy and safety of once weekly IcoSema and once weekly insulin icodec, both treatment arms with or without oral anti-diabetic drugs, in participants with type 2 diabetes inadequately controlled with daily basal insulin.

GERAS Study - Longitudinal Cohort Study of Resource use and Cost of Mild Cognitive Impairment and Mild Dementia due to Alzheimer's Disease in the United States

AXSOME Study - A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety Of AXS-05-AD-301 For the Treatment of Agitation in Subject with Dementia of the Alzheimer’s Type 

DEVOTE Study - A trial comparing Cardiovascular Safety of insulin degludec versus insulin glargine in subjects with type II diabetes and high-risk cardiovascular events 

PIONEER 3 Study - Efficacy and long-term safety of oral semaglutide vs. sitagliptin in subjects with type 2 diabetes 

PIONEER 4 Study - Efficacy and Safety of Oral Semaglutide vs. Liraglutide and vs. Placebo in subjects with type 2 Diabetes Mellitus

A Trial comparing the efficacy and safety of insulin degludec and insulin glargine 300 units/mL in subjects with type 2 diabetes mellitus inadequately treated with basal insulin with or without
oral anti-diabetic drugs (NN1250-4252)

SEPRA Study - Long Term comparative effectiveness of once weekly semaglutide vs. standard of care in a real
world adult US population with T2D – a randomized pragmatic clinical trial.

CAGRI-SEMA Study - Efficacy and safety of co-administration of cagrilintide s.c. 2.4 mg and semaglutide s.c. 2.4 mg once weekly in subjects with type 2 diabetes. (NN9838-4862)

A Phase III study, Randomized, Double-Blind, Placebo-Controlled
Study to evaluate the Efficacy and Safety of Tetracycline in patients with Rheumatoid Arthritis

A Multicenter, Randomized, Double-Blind, Placebo-Controlled
Study to Evaluate the Efficacy and safety of Subcutaneous LY2127399 in Patients with Systemic Lupus Erythematosus (SLE)

An informational study on patients with type II diabetes and CKD of stage II or higher

CHAMP Study - Observational Registry of Treatment patterns in U.S. Heart Failure Patients with Reduced Ejection Fraction.